Navigation Links
Fundamental discovery -- Bone fracture

A startling discovery about the properties of human bone has been made by scientists at the University of California, Santa Barbara.

The scientists describe their results –?finding a sort of "glue" in human bone –?in the cover story of the August issue of the international scientific journal, Nature Materials.

The article was published on-line on July 17. It describes how healthy bone resists fracture and how unhealthy bone fractures at the molecular level. Included with the article are the highest resolution images of bone ever published, which reveal the location of the adhesive or "glue" that holds together mineralized collagen fibrils (protein fibers) of bone.

The glue appears to contain "springs" that uncoil when the bone is stressed, helping the bone to absorb shock. When the stress is relaxed, they coil back to their original structure.

The possible implications for human health are important, explained Georg E. Fantner, a UCSB doctoral student in physics and first author of the report. "The findings may lead to therapy for bone fracture, or even to prevention," he said.

Working in the physics laboratory of Professor Paul K. Hansma, in collaboration with the UCSB labs of Professors Daniel E. Morse and Galen D. Stucky, the interdisciplinary group of scientists spent several years tracking down where the glue was located in bone, and how it worked.

"Before this research, it was well known that the mechanical properties of bone depended on mineral particles and on collagen fibrils," said Hansma. "The picture of bone was that it consisted of these collagen fibrils coated with tiny mineral crystals only a few atoms thick. What we found is that there is a glue in bone that holds these mineralized collagen fibrils together, and this glue works along the same principles that our interdisciplinary research group found in abalone shells. This glue involves sacrificial bonds (with hidden length) that uncoil when the bone is stressed." That interdisciplinary research group included the research groups of Morse and Stucky, as well as that of Herbert J. Waite.

Said co-author Daniel Morse, director of UCSB's Institute for Collaborative Biotechnologies: "It's especially exciting for us to find the profound medical significance of our discoveries for human bone." He described the discovery of "molecular shock absorbers" providing a kind of self-healing glue holding biological mineralized structures together when studying the abalone shell six years ago. "It's truly remarkable to find the same fundamental mechanisms operating in bone," said Morse.

He noted that these mechanisms give young healthy bone its tremendous resiliency and resistance to fracture, and actually help heal small microcracks soon after they're formed. "We're especially interested in learning how these molecules change and become depleted with age as well as in certain diseases," said Morse. "A potential benefit from these discoveries is the prospect that we might now learn how to protect bone from these deleterious changes, and perhaps actually reverse some of the changes."

Hansma explained, "The thing that's exciting about this research is that we've identified a mechanically important component of bone." When the exact molecules are identified, these can then become therapeutic targets, for example, diet, or drug therapy. He said the group has made a fundamental discovery of something that's important for bone fracture resistance that was previously unknown. Now the degradation mechanisms and deficiencies can be studied. "If you don't know something is important then you can't do anything about it. This is a fundamental and new discovery in an old and well-studied field," Hansma added.

He noted that bone fracture is a serious problem for elderly people, especially those with osteoporosis. Bone fracture is one of the leading factors in decreasing quality of life for the elderly. "Cancer an d heart disease can kill you but bone fracture and arthritis make you miserable," he said. "Once a serious bone fracture occurs, then quality of life goes down. Less than one-third of elderly women who have a hip fracture return to previous function. More women die within a year of hip fracture than die after a heart attack. So it's a very serious problem and a lot of work has been done to develop good diagnostics. The leading diagnostic is bone mineral density."

Measuring bone mineral density is valuable because it reveals how much bone a person has left. The amount of an individual's bone mineral density peaks around age 30, then decreases for the rest of his or her life. By the time the person becomes elderly, very serious bone loss may have occurred.

"As if this weren't bad enough, it is also true that the materials properties of the bone decrease with age," said Hansma. "Not only is there less bone, but what exists is less strong. The cause of this is not well understood. Our research is aimed at understanding that."

Hansma noted that bone has been studied extensively since Galileo. "Galileo wrote a really nice paper about bone, describing why elephants need thicker bones than small animals." He said that a paper on bone is published every six minutes. And although bone is extensively studied, little is known about how it works at the molecular level. "Our paper is the beginning research on this."

Hansma and his colleagues at UCSB have pioneered the use of the Atomic Force Microscope (AFM) in looking at the nano-scale level of biological materials ?down to a billionth of a meter. Before the use of the AFM, it was impossible to see these tiny molecular structures.


'"/>

Source:University of California - Santa Barbara


Related biology news :

1. Fundamental Finding Yields Insight into Stem Cells, Cancer; Opens Door to Drug Discovery
2. Protein discovery could unlock the secret to better TB treatment
3. Purdue proves concept of using nano-materials for drug discovery
4. UCSD discovery may help extend life of natural pesticide
5. Leprosy microbes lead scientists to immune discovery
6. Biochemists report discovery of structure of major piece of telomerase; implications for cancer
7. Researchers make surprise discovery that some neurons can transmit three signals at once
8. Important discovery about second most fatal cancer
9. Harmless virus may hold key to more effective HIV drug discovery
10. Genetic discovery could lead to drought-resistant plants
11. Gene discovery sheds light on causes of rare disease, cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/2/2016)... RESTON, Va. , Feb. 2, 2016 /PRNewswire/ ... contract award from the U.S. Army Research Office ... extend the range and sensitivity of the company,s ... DoD,s Past Accounting Mission and, more generally, defense-related ... its DNA phenotyping capabilities (predicting appearance and ancestry ...
(Date:2/1/2016)... Canada , February 1, 2016 ... technological advancements to drive global touchfree intuitive gesture control ... --> Rising sales of consumer electronics coupled ... gesture control market size through ... consumer electronics coupled with new technological advancements to drive ...
(Date:2/1/2016)... wallet ( www.wocketwallet.com ) announces the launch of a new video featuring ... Las Vegas , where Joey appeared at the Wocket booth ... , where Joey appeared at the Wocket booth to meet and ... at the Consumer Electronics Show (CES2016) in Las Vegas ... fans. --> --> The video ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... , ... February 10, 2016 , ... ... medicine, has announced a new agreement with Singapore-based Global Stem Cells Network (GSCN) ... the Philippines, Thailand and Singapore in the latest adipose and bone marrow therapies. ...
(Date:2/9/2016)... 9, 2016  Regenicin, Inc. (OTC Bulletin Board: ... the development and commercialization of regenerative cell therapies ... organs, recently reported the Company,s operating results for ... 2016. Lonza America , Inc. (the ... year in the process of consummating an agreement ...
(Date:2/9/2016)... King of Prussia, PA (PRWEB) , ... February 09, 2016 , ... ... Director, Business Development, Europe. Based in Paris, he will focus on acquiring new ... needs are being met. , “Fred brings to our European clients ...
(Date:2/9/2016)... 9, 2016  DNAtrix, a clinical stage, ... announced that its lead product, DNX-2401, has ... an orphan medicinal product for the treatment ... glioma, strikes approximately 25,000 people a year ... http://photos.prnewswire.com/prnh/20160208/330986LOGO --> http://photos.prnewswire.com/prnh/20160208/330986LOGO ...
Breaking Biology Technology: